EMAIL
(for adverse events, product quality feedback,
medical enquiries)
PHONE NUMBER
(for adverse events, product quality feedback, medical enquiries)
Celltrion Healthcare New Zealand Ltd
Floor 1, 103 Carlton Gore Road, Newmarket,
Auckland, 1023, NZ
THIS SITE IS DESIGNED FOR THE GENERAL PUBLIC IN NEW ZEALAND.
PRESCRIPTION MEDICINE. Herzuma (trastuzumab biosimilar) is a prescription-only medicine containing trastuzumab. Herzuma powder for intravenous infusion is available as: (i) Herzuma 150mg vial containing 150mg of trastuzumab and (ii) Herzuma 440mg vial containing 440mg of trastuzumab.
USES OF HERZUMA. Herzuma is prescribed for adult patients with HER2-positive: (i) early breast cancer, (ii) metastatic breast cancer, and/or (iii) advanced stomach cancer or gastro-oesophageal junction cancer. Use strictly as directed.
RISKS AND BENEFITS. Herzuma has risks and benefits. Always discuss your condition and treatment plan with your healthcare professional to determine if Herzuma is right for you. If you have any specific questions about how Herzuma might affect your treatment, side effects, or interactions with other medications, please seek their advice. If symptoms continue or you have side effects, see your doctor, pharmacist or healthcare professional. Normal doctor's charges apply.
NZ-HER-25-00001. Last updated April 2025. TAPS BG4906.